BACE1 and amyloidosis: Our results indicated that berberine was beneficial to decrease the generation of Aβ1-42 via inhibiting the enzymatic activity of BACE1, and disrupt the aggregation of Aβ1-42 into amyloid plaques (Figure 6D).